e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Biological correlates of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage
E. C. Creutzberg, A. Schilstra, R. Broekhuizen, E. F. M. Wouters (Horn, Maastricht, The Netherlands)
Source:
Annual Congress 2004 - Biological correlates of COPD
Session:
Biological correlates of COPD
Session type:
Thematic Poster Session
Number:
510
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. C. Creutzberg, A. Schilstra, R. Broekhuizen, E. F. M. Wouters (Horn, Maastricht, The Netherlands). The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage. Eur Respir J 2004; 24: Suppl. 48, 510
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Patients with COPD have low level of knowledge about their disease
Source: Eur Respir J 2005; 26: Suppl. 49, 516s
Year: 2005
COPD patients with more severe GOLD stages have higher serum cystatin C levels
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012
Serum TGF-β level in patients with different stages of stable COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Prevalence of co-morbidities in Greek COPD patients in relation to the stage of the disease (COMPACT study)
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Haemoglobin level and its clinical impact in a cohort of patients with COPD
Source: Eur Respir J 2007; 29: 923-929
Year: 2007
High prevalence of undiagnosed COPD in patients with cardiovascular disease
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Content of adiponectin in blood of COPD patients depending on stage of disease and presence of emphysema
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
High prevalence of COPD symptoms in the Tunisian population contrasting with low awareness of the disease
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Low hematocrit as predictor of exacerbation frequency in COPD patients
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
High prevalence of COPD symtoms in the Tunisian population contrasting with low awareness of the disease
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Comorbidities in COPD patients are not associated to higher disease severity
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
High prevalence of COPD among adults with heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
COPD characteristics and progression of patients with high vs low health status: an analysis of the observational DACCORD study
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
Distribution of severity of patients with obstructive lung disease in an at risk population
Source: Eur Respir J 2004; 24: Suppl. 48, 474s
Year: 2004
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Patients at risk for COPD compared to patients diagnosed with COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Prevalence of comorbidity in patients with COPD and its effect on mortality
Source: Annual Congress 2003 - Staging and outcome in COPD
Year: 2003
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
High prevalence of osteoporosis in COPD patients independent of GOLD stage
Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept